Article

Must-See Sessions for ASHP Midyear 2017

ASHP’s 2017 Midyear Clinical Meeting is set to begin, and Pharmacy Times will be on site covering it.

The holidays are just around the corner, but that’s not the only exciting thing about this time of year.

ASHP’s 2017 Midyear Clinical Meeting kicked off this weekend in Orlando, and Pharmacy Times is on site covering it. At this largest gathering of clinical pharmacists in the world, there will be plenty of opportunities to dive into a number of informative sessions covering everything from patient care to medication safety, and more.

Here are 4 sessions to watch for in our coverage at this year’s meeting:

Opening Session

This session is always popular and this year's discussion, which will feature a moderated conversation with Former First Lady Michelle Obama promises to be an interesting opener for the meeting.

ISMP Symposium

Interested in medication safety practices? This session will identify the most important medication safety issues reported to the Institute for Safe Medication Practices (ISMP), and will provide pharmacists with effective strategies to reduce medication errors.

FDA Update 2017: Public Health and Regulatory Initiatives Impacting Today's Practice

Learn key information on new FDA initiatives and goals, along with the FDA’s Division of Drug Information’s role in public health and the potential impact of these initiatives on pharmacists and their practices. Featured presenters will include Adesola Adejuwon, PharmD, and Lindsay Wagner, PharmD, both with the FDA.

Parenteral Nutrition: New Clinical Guidance for Patient Selection and Management

This session will address the challenges for identifying evidence-based indications for pareneral nutrition therapy.

The conference will be taking place December 3-7, so be sure to watch for Pharmacy Times’ ASHP conference dailies and coverage on social media.

Related Videos
Young female pharmacist working in her large pharmacy. Placing medications, taking inventory. Lifestyle - Image credit: lubero | stock.adobe.com
Image Credit: © utah51 - stock.adobe.com
Image Credit: © Rawpixel.com - stock.adobe.com
Image Credit: © RandyJay - stock.adobe.com
Image Credit: © nimito - stock.adobe.com
WCLC, lung cancer, NSCLC
MARIPOSA Study: Long-Term Outcomes and Next Steps for Amivantamab Plus Lazertinib in EGFR-Mutant NSCLC
Pharmacist helping patient -- Image credit: Clayton D/peopleimages.com | stock.adobe.com
The EMPOWER-Lung 1 Trial: Five-Year Outcomes of Cemiplimab Monotherapy in Advanced NSCLC